Deferasirox (marketed as Exjade) is an oral iron chelator. Its main use is to reduce chronic iron overload in patients who are receiving long term blood transfusions for conditions such as beta-thalassemia and other chronic anemias. It is the first oral medication approved for this purpose.

It was approved by the FDA in November 2005.

Chelating agents